Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia
· Delayed Price · Currency is AUD 3.290
-0.290 (-8.10%)
At close: Mar 9, 2026
Clarity Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2018 |
| Net Income | -96.35 | -64.3 | -42.32 | -24.6 | -23.75 | -10.22 | Upgrade
|
| Depreciation & Amortization | 0.25 | 0.19 | 0.15 | 0.1 | 0.05 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0 | - | - | 0 | Upgrade
|
| Stock-Based Compensation | 6.12 | 6.12 | 4.17 | 1.25 | 8.77 | 2.07 | Upgrade
|
| Other Operating Activities | 14.5 | - | - | - | 0 | - | Upgrade
|
| Change in Accounts Receivable | 2.54 | 2.54 | -2.63 | -3.34 | -3.29 | -0.71 | Upgrade
|
| Change in Accounts Payable | 1.57 | 1.57 | 0.26 | 0.02 | 5.01 | 1.07 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -0.08 | -0.03 | Upgrade
|
| Change in Other Net Operating Assets | -0.89 | -0.89 | -2.87 | -0.92 | -0.01 | 0.13 | Upgrade
|
| Operating Cash Flow | -72.26 | -54.77 | -43.24 | -27.5 | -13.31 | -7.68 | Upgrade
|
| Capital Expenditures | -0.34 | -0.18 | -0.5 | -0.05 | -0.21 | -0.06 | Upgrade
|
| Investment in Securities | -47.58 | 52.17 | -54.8 | 3.2 | -26.5 | -9.5 | Upgrade
|
| Investing Cash Flow | -47.91 | 51.99 | -55.31 | 3.15 | -26.71 | -9.56 | Upgrade
|
| Issuance of Common Stock | 204.21 | 2.4 | 121.86 | 0.24 | 92.53 | 21.1 | Upgrade
|
| Other Financing Activities | -10.77 | -0.19 | -6.65 | -0.01 | -5.6 | -0.68 | Upgrade
|
| Financing Cash Flow | 193.45 | 2.21 | 115.21 | 0.23 | 86.93 | 20.41 | Upgrade
|
| Foreign Exchange Rate Adjustments | -5.8 | 0.35 | 0.02 | -0.01 | -0 | -0 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | 67.48 | -0.22 | 16.69 | -24.12 | 46.9 | 3.17 | Upgrade
|
| Free Cash Flow | -72.59 | -54.95 | -43.74 | -27.55 | -13.53 | -7.74 | Upgrade
|
| Free Cash Flow Margin | -686.15% | -580.71% | -380.14% | -281.07% | -209.43% | -242.06% | Upgrade
|
| Free Cash Flow Per Share | -0.21 | -0.17 | -0.16 | -0.11 | -0.06 | -0.04 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0 | Upgrade
|
| Cash Income Tax Paid | 0.96 | 0.72 | 0.08 | 0.1 | 0.02 | - | Upgrade
|
| Levered Free Cash Flow | -44.47 | -33.7 | -29.16 | -19.59 | -7.23 | -3.9 | Upgrade
|
| Unlevered Free Cash Flow | -44.47 | -33.7 | -29.16 | -19.59 | -7.23 | -3.9 | Upgrade
|
| Change in Working Capital | 3.22 | 3.22 | -5.24 | -4.25 | 1.63 | 0.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.